XJPX
2267
Market cap5.04bUSD
Jul 09, Last price
2,836.50JPY
1D
-2.86%
1Q
7.16%
Jan 2017
-47.67%
Name
Yakult Honsha Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Tokyo, Japan, in 1935, Yakult Honsha Co., Ltd. is a diversified corporation engaged in the creation and sale of a broad spectrum of goods. Its principal activities span food and beverage items, beauty products, and pharmaceutical drugs. The company's extensive food and beverage division operates across several global territories, including Japan, the Americas, Asia and Oceania, and Europe. This segment provides various offerings such as fermented milk beverages, juices, and noodles, which are distributed to consumers through both direct-to-home delivery services and conventional retail outlets. Within its pharmaceutical operations, Yakult Honsha focuses on developing and commercializing specialized medicines. These include the anti-cancer medication Elplat, along with generic versions of anti-tumor agents like Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Beyond these core areas, Yakult Honsha also participates in the cosmetics sector and notably owns a professional sports franchise, the Tokyo Yakult Swallows baseball team.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||